Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest update is out from Biocure Technology Inc ( ($TSE:CURE.X) ).
Biocure Technology Inc. has announced a debt settlement agreement to issue 4,762,500 common shares at $0.05 per share to settle $238,125 of debt with certain creditors, including a related party transaction involving three company directors. This move aims to improve the company’s working capital as it seeks acquisition opportunities, subject to Canadian Securities Exchange approval and a statutory hold period.
More about Biocure Technology Inc
Biocure Technology Inc. operates in the biotechnology industry, focusing on developing innovative medical solutions. The company is involved in acquiring and improving its working capital position to enhance its operational capabilities.
Average Trading Volume: 5,042
Technical Sentiment Signal: Sell
Current Market Cap: C$522.2K
For detailed information about CURE.X stock, go to TipRanks’ Stock Analysis page.